Eyebot

Boston, MA · Founded 2021 · Privately Held (backing)

Developer of an eye examination technology designed to eliminate barriers and provide quality vision care. Eyebot is based in Boston, MA and was founded in 2021. Its last reported valuation was $107 million in Aug 2025. It has raised $28.3 million.

Last reported valuation
$107.0M
Oct 2026
Priced at
—
Total raised
$28.3M
Last round
—

Who backs Eyebot?

10 investors
InvestorType
US National Science FoundationOther
General CatalystVenture capital
Village GlobalOther
AlleyCorpVenture capital
MassVenturesOther
Spacecadet VenturesVenture capital
Humba VenturesVenture capital
BaukunstVenture capital
Ravelin CapitalVenture capital
Ubiquity Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Eyebot investors

10 investors are on record for Eyebot, including US National Science Foundation, General Catalyst, Village Global and AlleyCorp. By type, the record holds 6 venture capital firms.

Free account
More of Eyebot with a free account
  • ·Watch Eyebot: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Eyebot. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View